Pu Xia

2.8k total citations
74 papers, 1.6k citations indexed

About

Pu Xia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pu Xia has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 33 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Pu Xia's work include Cancer Cells and Metastasis (20 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Pu Xia is often cited by papers focused on Cancer Cells and Metastasis (20 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Pu Xia collaborates with scholars based in China, United States and Japan. Pu Xia's co-authors include Xiaoyan Xu, Xifeng Wu, Yuanqing Ye, Hua‐chuan Zheng, Jian Gu, Jie Lin, Yasuo Takano, Michelle A.T. Hildebrandt, Da-Hua Liu and Anna Dubrovska and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Pu Xia

72 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pu Xia China 21 892 522 461 297 182 74 1.6k
Tao Tian China 26 1.0k 1.1× 499 1.0× 645 1.4× 296 1.0× 278 1.5× 107 2.0k
Jingdong Zhang China 23 689 0.8× 629 1.2× 373 0.8× 352 1.2× 151 0.8× 118 1.7k
Keqiang Zhang China 29 1.2k 1.3× 456 0.9× 682 1.5× 267 0.9× 176 1.0× 75 1.9k
Takafumi Nishimura Japan 21 823 0.9× 639 1.2× 286 0.6× 269 0.9× 165 0.9× 51 1.8k
Chenyue Zhang China 22 680 0.8× 578 1.1× 465 1.0× 303 1.0× 113 0.6× 74 1.4k
Haiyong Wang China 27 867 1.0× 550 1.1× 477 1.0× 370 1.2× 134 0.7× 83 1.8k
Bangwei Cao China 25 860 1.0× 624 1.2× 482 1.0× 325 1.1× 233 1.3× 94 1.9k
Shaoyu Yan United States 25 910 1.0× 595 1.1× 326 0.7× 421 1.4× 115 0.6× 39 1.9k
Limei Liu China 22 1.1k 1.3× 565 1.1× 507 1.1× 125 0.4× 148 0.8× 42 1.7k
Ming Jin China 20 643 0.7× 452 0.9× 351 0.8× 225 0.8× 125 0.7× 79 1.5k

Countries citing papers authored by Pu Xia

Since Specialization
Citations

This map shows the geographic impact of Pu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu Xia more than expected).

Fields of papers citing papers by Pu Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu Xia. The network helps show where Pu Xia may publish in the future.

Co-authorship network of co-authors of Pu Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Pu Xia. A scholar is included among the top collaborators of Pu Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pu Xia. Pu Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Xifeng, Chi Pang Wen, Yuanqing Ye, et al.. (2020). Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Scientific Reports. 10(1). 5514–5514.
3.
Tian, Shuang, Da-Hua Liu, Dan Wang, Fu Ren, & Pu Xia. (2018). Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression. Cellular Physiology and Biochemistry. 51(1). 217–227. 8 indexed citations
4.
Xia, Pu & Xiaoyan Xu. (2017). DKK3 attenuates the cytotoxic effect of natural killer cells on CD133+ gastric cancer cells. Molecular Carcinogenesis. 56(7). 1712–1721. 16 indexed citations
5.
Hildebrandt, Michelle A.T., Xifeng Wu, Pu Xia, et al.. (2017). Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors. Scientific Reports. 7(1). 9698–9698. 28 indexed citations
6.
Wang, Dan, et al.. (2016). The roles of serum PDCD5 in circulating CD133 positive cells of the patients with gastric cancer. Tumor Biology. 37(9). 11799–11804. 4 indexed citations
7.
Williams, Stephen B., Yuanqing Ye, Maosheng Huang, et al.. (2015). Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms. Cancer Prevention Research. 8(7). 607–613. 17 indexed citations
8.
Sun, Wenjie, Chi-Pang Wen, Jie Lin, et al.. (2015). ABO blood types and cancer risk—A cohort study of 339,432 subjects in Taiwan. Cancer Epidemiology. 39(2). 150–156. 29 indexed citations
9.
Wen, Chi-Pang, Fanmao Zhang, Dong Liang, et al.. (2014). The Ability of Bilirubin in Identifying Smokers with Higher Risk of Lung Cancer: A Large Cohort Study in Conjunction with Global Metabolomic Profiling. Clinical Cancer Research. 21(1). 193–200. 50 indexed citations
10.
Xia, Pu, Jack A. Roth, Michelle A.T. Hildebrandt, et al.. (2013). MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients. Cancer Research. 73(6). 1867–1875. 35 indexed citations
12.
Xia, Pu, Wenfeng Gou, Jinjin Wang, et al.. (2013). Distinct Radiosensitivity of Lung Carcinoma Stem-Like Side Population and Main Population Cells. Cancer Biotherapy and Radiopharmaceuticals. 28(6). 471–478. 14 indexed citations
13.
Xia, Pu, Yuanqing Ye, Margaret R. Spitz, et al.. (2012). Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study. Clinical Cancer Research. 18(21). 5983–5991. 11 indexed citations
14.
Wilkinson, Anna V., Melissa L. Bondy, Xifeng Wu, et al.. (2012). Cigarette Experimentation in Mexican Origin Youth: Psychosocial and Genetic Determinants. Cancer Epidemiology Biomarkers & Prevention. 21(1). 228–238. 15 indexed citations
15.
Liang, Dong, Larissa A. Meyer, David W. Chang, et al.. (2010). Genetic Variants in MicroRNA Biosynthesis Pathways and Binding Sites Modify Ovarian Cancer Risk, Survival, and Treatment Response. Cancer Research. 70(23). 9765–9776. 102 indexed citations
16.
Zheng, Hua‐chuan, Pu Xia, Xiaoyan Xu, et al.. (2010). The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.. PubMed. 25(4). 445–52. 32 indexed citations
17.
Xie, Yun, et al.. (2010). Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy. Journal of Viral Hepatitis. 18(12). 877–883. 75 indexed citations
18.
Zheng, Hua‐chuan, Xiaoyan Xu, Pu Xia, et al.. (2010). Involvement of inactive GSK3β overexpression in tumorigenesis and progression of gastric carcinomas. Human Pathology. 41(9). 1255–1264. 16 indexed citations
19.
Xia, Pu, Scott M. Lippman, Hushan Yang, J. Jack Lee, & Xifeng Wu. (2009). Cyclooxygenase‐2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer. 115(7). 1498–1506. 21 indexed citations
20.
Xia, Pu. (2003). Study on relationship between paraoxonase-1 and type 2 diabetes mellitus in the elderly. Zhonghua laonian yixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026